A detailed history of 360 Financial, Inc. transactions in Amgen Inc stock. As of the latest transaction made, 360 Financial, Inc. holds 1,969 shares of AMGN stock, worth $625,137. This represents 0.23% of its overall portfolio holdings.

Number of Shares
1,969
Previous 1,969 -0.0%
Holding current value
$625,137
Previous $559,000 10.02%
% of portfolio
0.23%
Previous 0.22%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021

BUY
$216.38 - $257.67 $64,914 - $77,301
300 Added 17.97%
1,969 $453,000
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $23,465 - $26,095
100 Added 6.37%
1,669 $424,000
Q4 2019

Feb 28, 2020

BUY
$189.21 - $243.2 $296,870 - $381,580
1,569 New
1,569 $357,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $170B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track 360 Financial, Inc. Portfolio

Follow 360 Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 360 Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on 360 Financial, Inc. with notifications on news.